Resources Contact Us Home
Modified leukotoxin protein

Image Number 15 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Extending outdoor location based services and applications into enclosed areas
Bump structure including nano-wires and a body connecting ends of the nano-wires, semiconductor package having the bump structure and method of manufacturing the semiconductor package
Graph matching system for comparing and merging fault models
Non-aqueous electrolyte secondary battery, electrode used for secondary battery, and method of manufacturing electrode
Radiation-curable formulations
Substituted alkylamine derivatives and methods of use
Compiler capable of partitioning program and program partitioning method
  Randomly Featured Patents
Image capturing apparatus, image capturing method, and computer-readable medium storing a program for an image capturing apparatus
Human cytomegalovirus neutralizing antibodies and use thereof
Head carriage for use with a longitudinal recording system utilizing a rotary recording and/or reproducing head
Semiconductor device and manufacturing method
Poinsettia plant named `Fisson Jinglit`
Developmental language system for infants
Assembly tape with perforation and expansion reserve
Verifying performance of a buffering and selection network device
Sealable squib connector system
Manual backup system for controlling fluid flow to cylinders within an agricultural implement